Decomposable Polyelectrolyte Films for Sustained Drug Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current layer-by-layer (LbL) assembly methods for drug delivery using polyelectrolyte films face challenges in controlled release of hydrophobic small molecules due to diffusion-based release patterns and the use of harsh solvents, which limits the duration and control of drug release.

Innovation Solution

Incorporation of cyclodextrins into LbL thin film coatings as carriers for hydrophobic small molecules, utilizing polycyclodextrins to prevent undesired diffusion and employing sequential degradation of decomposable layers for controlled release, with degradable polyelectrolyte layers that are hydrolyzable, allowing for sustained release over several days.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If diffusion-based release is used from uniform LbL films, then drug release can occur from the film surface, but the release duration is limited to a few hours and the release pattern is nonlinear

Engineering Contradiction:
Improverelease durationVSAvoidrelease control
Core Design Contradiction:
Duration of action of moving objectVSProductivity

Solution Approach 1:

The film is segmented into multiple degradable layers with alternating charges, where each layer can be removed sequentially. This segmentation enables extended release duration by breaking down the uniform film structure into manageable segments that degrade at different rates, transforming the release mechanism from rapid diffusion to controlled sequential degradation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The film transitions from a static uniform structure to a dynamic multi-layer structure that changes over time through sequential degradation. The alternating charge layers create a dynamic system where the film morphology and release characteristics evolve during the degradation process, enabling sustained release beyond the initial diffusion phase.

Inventive Principle:
Principle #15Dynamics

2Ease of manufacture

If harsh solvents are used in processing LbL films, then film formation can be achieved, but the bioactive agent may be destroyed

Engineering Contradiction:
Improvefilm formationVSAvoidagent degradation
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The processing conditions are changed from harsh solvents to aqueous or mild environments. By adjusting the chemical parameters of the processing medium, the film can be formed without exposing the bioactive agent to destructive conditions, thus preventing agent degradation while maintaining manufacturability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

An intermediary carrier system is introduced between the processing environment and the bioactive agent. This intermediary protects the agent from harsh processing conditions while still allowing the film to be formed, effectively mediating between manufacturing requirements and agent stability.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If hydrophobic small molecules are incorporated into LbL films, then drug delivery can be achieved, but the molecules may not adsorb readily onto polyelectrolyte layers due to lack of charge density

Engineering Contradiction:
Improveagent loadingVSAvoidadsorption efficiency
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

A cyclodextrin carrier is introduced as an intermediary between the hydrophobic small molecule and the polyelectrolyte layer. The cyclodextrin forms inclusion complexes with the hydrophobic molecules, providing the necessary charge density and surface area for effective adsorption onto the polyelectrolyte layers, thus improving both loading and adsorption efficiency.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The film composition is enhanced by incorporating cyclodextrin carriers into the polyelectrolyte matrix, creating a composite material system. This composite structure combines the hydrophobicity management capabilities of cyclodextrins with the charge-based adsorption properties of polyelectrolytes, enabling effective incorporation and retention of hydrophobic small molecules.

Inventive Principle:
Principle #40Composite materials

4Duration of action of moving object

If sequential degradation of layers is used for controlled release, then sustained release over several days can be achieved, but the film structure becomes more complex

Engineering Contradiction:
Improverelease durationVSAvoidfilm structure
Core Design Contradiction:
Duration of action of moving objectVSDevice complexity

Solution Approach 1:

The film is divided into multiple degradable layers with alternating charges, where each layer can be removed sequentially. This segmentation enables extended release duration by breaking down the uniform film structure into manageable segments that degrade at different rates, transforming the release mechanism from rapid diffusion to controlled sequential degradation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the film are given different properties through the alternating charge layers. Each layer has distinct charge characteristics and degradation properties, creating local variations in the film structure that enable controlled sequential degradation while maintaining overall film integrity during the release process.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables controlled and sustained release of bioactive agents over extended periods, such as 2 to 12 days, while maintaining the integrity and function of the bioactive agents, avoiding the limitations of diffusion-based release and harsh processing conditions.

Implementation Method 1

at least one of the cyclodextrin molecules form a complex with the bioactive agent; in some such embodiments, the complex is an inclusion complex

Methodology Applied
Scientific EffectInclusion complex formation: Absorption (physical)

Implementation Method 2

the decomposable thin film comprises at least one degradable polyelectrolyte layer, wherein the degradable polyelectrolyte is hydrolyzable

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 3

LBL adsorption of oppositely charged polyelectrolytes on substrates can be used to fabricate thin multi-layer films

Methodology Applied
Scientific EffectElectrostatic adsorption: Adsorption

Data Source

PatentUS9198875B2Controlled delivery of bioactive agents from decomposable films
Publication Date: 2015.12.01 MASSACHUSETTS INST OF TECH
  • US9198875B2 patent drawing
  • US9198875B2 patent drawing
  • US9198875B2 patent drawing

AI summary

A decomposable thin film includes a plurality of multilayer units including a first layer having a first charge and a second layer having a second charge, wherein at least a portion of the multilayers includes a polymeric cyclodextrin associated with a bioactive agent, wherein decomposition of the thin film is characterized by sequential removal of at least a portion of the layers having the first charge and degradation of layers having the second charge and by release of the bioactive agent from a corresponding layers; wherein the decomposable thin film including at least one degradable polyelectrolyte layer that is hydrolyzable.